181 related articles for article (PubMed ID: 34568009)
1. The Clinicopathological and Prognostic Significance of SOX9 Expression in Gastric Cancer: Meta-Analysis and TCGA Analysis.
Zu G; Gao J; Zhou T
Front Oncol; 2021; 11():668946. PubMed ID: 34568009
[TBL] [Abstract][Full Text] [Related]
2. Lack of relationship between PROX1 expression and clinicopathological parameters and prognosis in gastric cancer patients: a meta-analysis and TCGA analysis.
Jia Z; Wang Y; Gao J; Zu G
BMC Gastroenterol; 2022 Mar; 22(1):142. PubMed ID: 35346069
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of SOX9 expression in gastric cancer patients: A meta-analysis.
Wang Q; Chen H; Yang C; Liu Y; Li F; Zhang C
Medicine (Baltimore); 2022 Sep; 101(37):e30533. PubMed ID: 36123852
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and Prognostic Value of USP22 Expression in Gastric Cancer: A Systematic Review and Meta-Analysis and Database Validation.
Wang Y; Jia Z; Gao J; Zhou T; Zhang X; Zu G
Front Surg; 2022; 9():920595. PubMed ID: 35784926
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of methionine sulfoxide reductases B3 is associated with poor prognosis in gastric cancer.
Ma X; Wang J; Zhao M; Huang H; Wu J
Oncol Lett; 2019 Jul; 18(1):465-471. PubMed ID: 31289518
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic value of lysyl oxidase expression in gastric cancer: a systematic review, meta-analysis and bioinformatic analysis.
Jia Z; Gao J; Wang Y; Zhou T; Zhang X; Zu G
Sci Rep; 2022 Oct; 12(1):16786. PubMed ID: 36202905
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and prognostic significance of the RUNX3 expression in gastric cancer: a systematic review and meta-analysis.
Liu B; Han Y; Jiang L; Jiang D; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2018 May; 53():122-128. PubMed ID: 29578091
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.
Zhang C; Ren X; Zhang W; He L; Qi L; Chen R; Tu C; Li Z
Bioengineered; 2020 Dec; 11(1):1112-1123. PubMed ID: 33124951
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of LKB1 expression in gastric cancer: a systematic review and meta-analysis.
Tan G; Liu B
Sci Rep; 2023 Jun; 13(1):8937. PubMed ID: 37264076
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
[TBL] [Abstract][Full Text] [Related]
13. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.
Hu L; Luo H; Wang W; Li H; He T
PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707
[TBL] [Abstract][Full Text] [Related]
14. Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis.
Ruan H; Hu S; Zhang H; Du G; Li X; Li X; Li X
Oncotarget; 2017 Dec; 8(68):113163-113173. PubMed ID: 29348895
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of Sry-related High Mobility Group Box 9 and Gastrokine-1 in Gastric Cancer and Their Relationships with Prognosis].
Chen JB; Xu GS; Cai XJ; Liu HT; Sun KL; Luo X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Jun; 41(3):315-322. PubMed ID: 31282324
[TBL] [Abstract][Full Text] [Related]
16. Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis.
Razmi M; Ghods R; Vafaei S; Sahlolbei M; Saeednejad Zanjani L; Madjd Z
Cancer Cell Int; 2021 Feb; 21(1):139. PubMed ID: 33639931
[TBL] [Abstract][Full Text] [Related]
17. Impact of clinicopathological parameters on survival after multiorgan resection among patients with T4 gastric carcinoma: a systematic review and meta-analysis.
Zu G; Zhang T; Li W; Sun Y; Zhang X
Clin Transl Oncol; 2017 Jun; 19(6):750-760. PubMed ID: 28054321
[TBL] [Abstract][Full Text] [Related]
18. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
19. The expression of SOX9, Tiam1, and PTEN is correlated with angiogenesis and prognosis in gastric cancer.
Lei L; He L; Chen K; Lv Z
Transl Cancer Res; 2020 Jun; 9(6):3998-4004. PubMed ID: 35117766
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression in gastric cancer: a systematic review and meta-analysis.
Liu G; Xiong D; Zeng J; Chen B; Huang Z
Onco Targets Ther; 2017; 10():4321-4328. PubMed ID: 28919781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
